Literature DB >> 24786660

Clinical and economic consequences of post-operative infections following major elective surgery in U.S. hospitals.

Ariel Berger1, John Edelsberg, Holly Yu, Gerry Oster.   

Abstract

BACKGROUND: The incidence and consequences of post-operative infections in patients undergoing major elective surgery is not well understood.
METHODS: Using a large U.S. healthcare claims database, we identified all patients who underwent major elective surgery between January 1, 2007, and December 31, 2009. For each such patient, date of the first-noted surgery during this period was designated as the index date. Patients who developed infections within 30 d of their index date were matched to those who did not using propensity score matching. We compared hospital readmissions, mortality, and total healthcare cost during the 30-d period following index date between patients who developed post-operative infections versus those who did not.
RESULTS: A total of 327,618 patients met all selection criteria. At 30 d following major elective surgery, 10.9% of patients had evidence of post-operative infections, 39% of which occurred during the index admission. In propensity-matched analyses, patients with post-operative infections were about five times as likely to be readmitted to hospital (11.3% vs. 2.1%) and more than twice as likely to die (0.8% vs. 0.3%) in the 30-d period following surgery; their average total healthcare cost was $8,417 higher ($29,229 vs. $20,812) (all comparisons, p<0.01).
CONCLUSION: Approximately one in 10 patients undergoing major elective surgery develop post-operative infections by day 30. Post-operative infections are associated with significantly worse clinical outcomes and higher total healthcare cost.

Entities:  

Mesh:

Year:  2014        PMID: 24786660     DOI: 10.1089/sur.2012.200

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  4 in total

1.  Cost-effectiveness of pre-operative Staphylococcus aureus screening and decolonization.

Authors:  Susan E Kline; Erinn C Sanstead; James R Johnson; Shalini L Kulasingam
Journal:  Infect Control Hosp Epidemiol       Date:  2018-09-20       Impact factor: 3.254

2.  Zinc Pyrithione Improves the Antibacterial Activity of Silver Sulfadiazine Ointment.

Authors:  Catlyn Blanchard; Lauren Brooks; Katherine Ebsworth-Mojica; Louis Didione; Benjamin Wucher; Stephen Dewhurst; Damian Krysan; Paul M Dunman; Rachel A F Wozniak
Journal:  mSphere       Date:  2016-09-14       Impact factor: 4.389

3.  [COVID-19 and resuming elective surgery. How do we get back to normal?]

Authors:  Florentino Fernandes Mendes
Journal:  Braz J Anesthesiol       Date:  2020-09-15

4.  COVID-19 and resuming elective surgery. How do we get back to normal?

Authors:  Florentino Fernandes Mendes
Journal:  Braz J Anesthesiol       Date:  2020-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.